We’re lowering our price target on Bristol Myers as two key overhangs persist
Bristol Myers Squibb shares dropped Thursday despite a solid quarterly beat and…
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.